Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 17/20 | 0.55 |
| ▸ | RXRB | P28702 | 8/20 | 0.55 |
| ▸ | RXRG | P48443 | 6/20 | 0.55 |
| ▸ | RARB | P10826 | 6/20 | 0.55 |
| ▸ | RARG | P13631 | 5/20 | 0.55 |
| ▸ | RARA | P10276 | 4/20 | 0.51 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.51 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8731089 | 0.88 | RXRA (0.54) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL9551744 | 0.88 | RXRA (0.63) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL4417565 | 0.88 | RXRA (0.52) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL7940005 | 0.87 | RXRA (0.51) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL1118855 | 0.87 | KDM1A (0.54) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL8460386 | 0.83 | RXRA (0.58) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL12620617 | 0.83 | GNG2 (0.53) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL8733241 | 0.78 | RARB (0.83) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL9551735 | 0.77 | RXRA (0.55) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL14377463 | 0.77 | RARB (0.72) | RXRARXRBRXRGRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0699178-B1 | TETRAHYDRONAPHTHYL AND CYCLOPROPYL SUBSTITUTED 1,3-BUTADIENES HAVING RETINOID-LIKE ACTIVITY | ALLERGAN INC (US) | 1998-06-24 | — | — | EP | disclosed |
| US-5602135-A | SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ARTHEROSCLEROSIS,IMMUNOLOGY, WOUND HEALING AGENT, VISION DEFECTS, SUNSCREEN AGENTS | ALLERGAN | 1997-02-11 | — | — | US | disclosed |
| EP-0724579-A1 | PHENYL OR HETEROARYL AND TETRAHYDRONAPHTHYL SUBSTITUTED DIENE COMPOUNDS HAVING RETINOID LIKE BIOLOGICAL ACTIVITY | Allergan (US) | 1996-08-07 | — | — | EP | disclosed |
| EP-0699178-A1 | TETRAHYDRONAPHTHYL AND CYCLOPROPYL SUBSTITUTED 1,3-BUTADIENES HAVING RETINOID-LIKE ACTIVITY | ALLERGAN, INC. (US) | 1996-03-06 | — | — | EP | disclosed |
| US-5475022-A | Treating acne | ALLERGAN, INC. (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1995011242-A1 | PHENYL OR HETEROARYL AND TETRAHYDRONAPHTHYL SUBSTITUTED DIENE COMPOUNDS HAVING RETINOID LIKE BIOLOGICAL ACTIVITY | ALLERGAN (US) | 1995-04-27 | — | — | WO | disclosed |
| WO-1994026687-A1 | TETRAHYDRONAPHTHYL AND CYCLOPROPYL SUBSTITUTED 1,3-BUTADIENES HAVING RETINOID-LIKE ACTIVITY | ALLERGAN, INC. (US) | 1994-11-24 | — | — | WO | disclosed |
| US-5344959-A | Skin disorders and anticancer agents | ALLERGAN, INC. (US) | 1994-09-06 | — | — | US | disclosed |